CHM Cannabis
Home > Boards > US Listed > Medical - Healthcare >

Female Health Company (FHCO)

Add FHCO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/10/2017 8:53:19 AM - Followers: 8 - Board type: Free - Posts Today: 0

Primary Logo

"As of July 27,2016"
38,500,000 A/S
29,052,667 O/S
Par Value:$0.01

"About FHC"

The Female Health Company manufactures, markets and sells the FC2 Female Condom.  FC2 is the only female-controlled product approved by the U.S. Food and Drug Administration (FDA) and cleared by the World Health Organization (WHO) that provides dual protection against unintended pregnancy and sexually transmitted infections (STI’s), including HIV/AIDS. For sexually active couples, male and female condoms are the only two FDA approved and marketed products that prevent the transmission of HIV/AIDS through sexual intercourse.  HIV/AIDS remains the leading cause of death worldwide amount women 15-44 years of age.  More than 50% of new HIV infections are women and 80% of infections are the result of heterosexual sex.

The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other government agencies which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries world-wide. The Company’s customer base consists primarily of a small number of customers who purchase large quantities. Due to the receipt and timing of large orders, the Company experiences some quarter to quarter fluctuation in unit sales.

The Female Health Company’s headquarters are located in Chicago, Illinois.  The Company has an office located in London, England and a manufacturing facility located in Selangor D.E., Malaysia.

"Zica Virus"

The recent emergence of the Zika virus creates a global health issue.  The Company can make a significant contribution to preventing the spread of Zika.On February 1, 2016 WHO declared the Zika virus a global emergency.  The Zika virus was first identified in 1947 in Uganda (name comes from Zika Forest in Uganda).  There were no epidemic of major issues attributable to the virus for decades.

The outbreak of the virus was detected in Brazil in May 2015.  Since May 2015:




It has become epidemic in Brazil and detected in 20 additional Latin American countries.




It has been detected in the U.S. (Los Angeles, Texas, and Florida to date).




It has been detected in Spain.


Some Zika babies may not be born with microcephaly but still suffer life-long complications, such as two-month-old Micaela Milagros Mendoza (pictured), a Venezuelan child who has Zika-related calcification in her brain and scarring in her retinas
Some Zika babies may not be born with microcephaly but still suffer life-long complications, such as two-month-old Micaela Milagros Mendoza (pictured), a Venezuelan child who has Zika-related calcification in her brain and scarring in her retinas

The virus is spreading and could become epidemic on a global basis.Scientists have confirmed there is a link between the virus and microencephaly, a condition that causes babies to be born with unusually small heads.There was a sharp rise in cases of microencephaly in Brazil concurrent with the Zika virus epidemic.Women who are or become pregnant and are infected may give birth to babies with microencephaly. It has also been linked to eye issues and the Guillain-Barre Syndrome, a rare neurological disorder that can result in paralysis.

The Zika virus is transmitted by mosquitoes.

Image result for aedes aegypti mosquitoImage result for aedes aegypti mosquitoImage result for aedes aegypti mosquitoImage result for aedes aegypti mosquitoImage result for aedes aegypti mosquito
See all images

Aedes aegypti

Aedes aegypti, the yellow fever mosquito, is a mosquito that can spread dengue fever, chikungunya, Zika fever, and yellow fever viruses, and other diseases. The mosquito can be recognized by white markings on its legs and a marking in the form of a lyre on the upper surface of its thorax. This mosquito originated in Africa, but is now found in tropical and subtropical regions throughout the world. The average wing length of female Ae. aegypti mosquitoes varies greatly.

In addition, Zika is transmitted through sexual intercourse.It has been reported present in both semen and urine.There has been a report the virus has also been transmitted through blood transfusions.There is the potential for a global epidemic and related births of children with microencephaly and other severe brain defects.The social and economic ramifications could be devastating.Prevention of the disease and pregnancy is critical to averting a global epidemic.Currently available prevention methods are very limited and include the following:




Mosquito control will reduce transmission of the disease in this manner.  It will not prevent pregnancy or other forms of disease transmission.




Female and male condoms and abstinence are the only methods that can prevent pregnancy and transmission of the virus through sex.

The Company’s FC2 female condom can make a major contribution to the prevention of a serious disease, the birth of deformed children and the extraordinary costs that would be incurred in caring for such children. 




The Company believes it is in a better position to make this contribution than any other female condom manufacturer, as the Company has 20 years of experience and a production facility with capacity of approximately 100 million units annually. 




The female condom is a better choice than male condoms due to the role of the women.  The perception of risk among informed women of giving birth to a deformed baby is likely to be high.




Education is a key factor in creating risk awareness and effecting prevention.



Active Zika outbreaks have been reported in at least 59 countries or territories, most of them in the Americas, according to the CDC. Brazil has been the country most affected. 

Africa: 1 country

Cape Verde 

Americas: 49 countries

Anguilla, Antigua and Barbuda, Argentina, Aruba, The Bahamas, Barbados, Belize, Bolivia, Bonaire, Brazil, British Virgin Islands, Cayman Islands, Colombia, Costa Rica, Cuba, Curaçao, Dominica, Dominican Republic, Ecuador, El Salvador, French Guiana, Grenada, Guadeloupe, Guatemala, Guyana, Haiti, Honduras, Jamaica, Martinique, Mexico, Nicaragua, Panama, Paraguay, Peru, Saba, Puerto Rico, Saint Barthelmy, Saint Lucia, Saint Martin, Saint Vincent and the Grenadines, Saint Eustatius, St. Maarten, St. Kitts and Nevis, Suriname, Trinidad and Tobago, Turks and Caicos, United States, U.S. Virgin Islands, Venezuela.

Asia: 1 country


Oceania/Pacific Islands: 8 countries 

American Samoa, Fiji, Kosrae, Federated States of Micronesia, Marshall Islands, New Caledonia, Papua New Guinea, Samoa, Tonga.

CHICAGO – April 6, 2016 – The Female Health Company (FHC) (NASDAQ-CM: FHCO) today announced that it has entered into a definitive merger agreement with Aspen Park Pharmaceuticals, Inc. (APP), a privately held company focused on the development and commercialization of oncology and men’s and women’s health therapeutics and consumer health products. The proposed merger, subject to certain closing conditions, including approval by a two-thirds vote of FHC stockholders, is expected to close in the third quarter of 2016 and has been approved by the boards of both companies.
  A special meeting of FHC shareholders is scheduled for October 31, 2016 to approve matters relating to the proposed merger.
The merged company, to be called Veru Healthcare Inc.

Aspen Park Pharmaceuticals, Inc. is a privately held therapeutics company focused on the development and commercialization of pharmaceutical and consumer health products for men’s and women’s health and oncology. For men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, gout, sexual dysfunction, and prostate cancer. For women, product candidates are for advanced breast and ovarian cancers and for female sexual health. Aspen Park Pharmaceuticals is planning to launch in the United States the PREBOOST™ OTC product for treating premature ejaculation in Q4 of fiscal 2016. Aspen Park Pharmaceuticals has offices in New York City, New York. For more information on PREBOOST™ OTC product visit http://preboost.com/ or for more information on APP visit http://aspenparkpharma.com/.












Corporate Headquarters
Female Health Company
515 N. State Street, Suite 2225
Chicago, IL 60654



CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#77   FHCO, a lot of insider buying for Latinachica 06/10/17 08:53:19 AM
#76   Opler Timothy has filed a new 13G, reporting wiltonio 05/23/17 10:33:00 AM
#75   I'm out. On to other opportunities. growtheport 12/19/16 05:01:29 PM
#74   Welcome SA owners of FHCO. growtheport 11/30/16 04:40:14 PM
#70   Agreed. If it's called off, watch the growtheport 10/26/16 01:19:35 PM
#69   I started feeling that way after 2cd extention.Now Badfoot 10/19/16 04:42:47 AM
#68   FHCO is misleading it's investors. ISS still supports antaltk 10/12/16 02:32:54 PM
#67   Revealed: Zika's life-threatening birth defects you DIDN'T know Badfoot 10/04/16 05:48:30 AM
#66   Check out the coverage on SeekingAllpha. No growtheport 09/16/16 04:05:17 PM
#65   Sept.20,2016 shareholders meeting on merger. Badfoot 09/11/16 05:58:48 AM
#63   Go FHCO!!! Badfoot 09/08/16 06:39:44 PM
#62   A/H LOOKING GOOD!!! Badfoot 09/08/16 06:39:16 PM
#61   Possible merger soon. Badfoot 09/08/16 06:38:45 PM
#60   A company in the green. Badfoot 09/08/16 06:38:05 PM
#59   So much for the rapid rise on PPS. growtheport 04/12/16 11:33:34 PM
#58   LOL name change to FIASCO cowboyinvestor69 04/06/16 01:46:26 PM
#57   Name change to FISACO. willlbone 04/06/16 01:08:26 PM
#56   Merger poison. willlbone 04/06/16 01:00:09 PM
#55   Shorted to all hell today it looks like. runningwithscissors 04/06/16 12:57:57 PM
#54   Up 80% YTD. growtheport 03/12/16 05:40:43 PM
#53   The below link talks about the expansion in 2012. JC8484 03/07/16 04:00:57 PM
#52   You've got a few things mixed up. growtheport 03/03/16 10:35:36 PM
#51   Agree JC8484 03/02/16 03:54:43 PM
#50   looks good here!!! real good!! GhostInTheMatrix 03/02/16 03:34:38 PM
#49   Hello all JC8484 03/02/16 09:34:10 AM
#48   The worst should be over for FHCO. growtheport 02/04/16 05:36:14 PM
#47   Aug. 31, 2015 (GLOBE NEWSWIRE) -- The Female GhostInTheMatrix 02/04/16 03:38:38 PM
#46   I remain optimistic about the Company’s future for GhostInTheMatrix 02/04/16 03:33:56 PM
#45   The Female Health Company Reports Fiscal 2016 First GhostInTheMatrix 02/04/16 03:31:51 PM
#44   ***FHCO JUST ADDED TO THE IHUB ZIKA BOARD*** GhostInTheMatrix 02/04/16 01:01:53 PM
#43   Just picked up 600 shares here, chart looking pj McMulligan 03/18/15 01:25:30 PM
#42   Hello, I bought in January 2012 and have JC8484 03/10/15 11:48:04 AM
#41   $FHCO huge radar!!! Penny Roger$ 02/03/15 02:57:55 PM
#40   thanks, grow. appreciate it. will comtinue motionjoe 10/22/14 12:00:55 PM
#39   Hi Joe. I'm new to this board, growtheport 10/19/14 10:07:34 PM
#38   new to this board. cash flow positive, motionjoe 10/08/14 01:20:55 PM
#37   Natural retraction back here to start the day. profund 10/03/14 10:18:49 AM
#36   FHCO 4.4 hearing continuation to 5.75 likely PAC 10/03/14 12:22:45 AM
#35   20M FLOAT 50M CONDOMS==========LETS GO!!! [SMART MONEY] 10/02/14 12:09:21 PM
#34   http://ih.advfn.com/p.php?pid=nmona&article=63633605 shanak10 09/15/14 11:53:19 AM
#33   Expecting a nice bounce here to $5, just stocky101 07/16/14 10:51:19 AM
#32   http://online.wsj.com/article/PR-CO-20131203-905533.html?dsk=y FY2013 Highlig free_bee 12/03/13 11:24:48 AM
#30   FHCO $7.14 mlkrborn 01/04/13 12:45:29 PM
#29   ~ $FHCO ~ Earnings posted, pending or coming Penny Roger$ 02/03/12 04:57:46 AM
#28   Gotta love this board.. Penny Roger$ 02/03/12 04:57:40 AM
#27   ~ $FHCO ~ Earnings posted, pending or coming Penny Roger$ 02/02/12 02:06:54 AM
#26   I think it might explain some of the ambulance_blues 09/06/09 02:15:38 AM
#25   AB, I'm wondering whether this article partially explains trendseeker 09/05/09 04:23:42 PM
#24   Article in TIME magazine. ambulance_blues 09/05/09 03:33:11 AM
#23   Replay of Q3 conference call available online. ambulance_blues 09/05/09 03:02:58 AM